MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations
Abstract
Authors
F Kroi S Depalma H El Alili A Verhoek S van Beekhuizen B Heeg